Medical Bellwether J&J Slips Despite Handily Beating Quarterly Views

Medical Bellwether J&J Slips Despite Handily Beating Quarterly Views

Dow Jones health care giant Johnson & Johnson easily topped second-quarter expectations and raised its full-year sales and profit outlook on Thursday, but JNJ stock slipped in early action.